Episode 97: Idiopathic Ocular Inflammation associated with Aflibercept with VBS Officers Dr. Albini, Dr. Moshfeghi, and Dr. Wykoff

IMG_4204.PNG

Disclosures: Dr. Albini has no relevant financial disclosures. Dr. Moshfeghi is a consultant for Regeneron. Dr. Wykoff is a speaker and consultant for Regeneron.

Live from the 6th annual Vit-Buckle Society meeting Drs. Tom Albini, Andrew Moshfeghi, and Charlie Wykoff join the show to discuss a hot issue in retina today, the aflibercept-associated idiopathic ocular inflammation cases that have been reported throughout the country over the past few months.